Read all the updates from day 2 of Breakthrough T1D's Clinical and Research Congress focused entirely on type 1 diabetes.

A new clinical trial is investigating tegoprubart with islet cell transplants in people with type 1 diabetes and kidney disease.

A new clinical trial funded by Breakthrough T1D recently launched and is testing islet cell transplantation paired with Eledon Pharmaceuticals’ investigational immunosuppression therapy tegoprubart in ...

Breakthrough T1D’s first-ever Clinical and Research Congress (CRC), focused entirely on type 1 diabetes (T1D), has come to a ...

Disease-modifying therapies (DMTs) are treatments that prevent, slow, or reverse type 1 diabetes (T1D) by preserving or restoring insulin-producing beta cells. While there are several DMTs in clinical ...

PHILADELPHIA, Pa., Oct. 12, 2026 – Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, announces the conclusion of the inaugural Breakthrough ...

National Diabetes Awareness Month is the perfect time to see what’s next in type 1 diabetes (T1D) research. On Sunday, November 15, Breakthrough T1D invites you to a free research update at the ...

The Breakthrough T1D Youth Ambassador Program (YA) was designed to cultivate youth leaders within the type 1 diabetes (T1D) community. Youth Ambassadors inspire others by sharing their T1D stories, ...

As we drive toward curing type 1 diabetes, we help make everyday life better for the people who face it.